Interestingly, blockade of TNFα reduces joint inflammation while inhibition of IL-1β protects against cartilage degradation in mouse arthritis models, suggesting the latter may be an attractive molecular target in the development of disease-modifying therapies [36]. Here, IL1B is linked to arthritic joint disease.